TIGER-2 Trial of Denufosol Is Enrolling Patients
This research is being done to study the safety and effectiveness of an investigational drug called denufosol tetrasodium Inhalation Solution (denufosol) in people with for mild cystic fibrosis lung disease. Click here for additional information. If you are interested in participating contact Carolyn Chapman at 410-955-1167 or by e-mail.

CF Foundation Wins Quality Improvement Award
The CF Foundation recieved a 2009 Health Quality Award from the National Committee for Quality Assurance. This prestigious award was given for the quality improvement work sponsored by the CF Foundation at care centers such as Johns Hopkins. Click here to view a video about the award.

Bronchitol Improves Lung Function in European Trial
Pharmaxis announced that inhaled Bronchitol improved lung function in a recently completed European Phase 3 trial. This inhaled medication increased FEV1 by 6.6% compared to placebo. For more information click here. If you are interested in participating in a trial of this medication at Johns Hopkins contact Karen Callahan at 443-287-8983 or by e-mail.

VX-809 Trial
The Inital trial of VX-809 at Johns Hopkins is now enrolling adults with CF. A description of the study can be obtained by clicking here. For more information contact Karen Callahan at  443-287-8983 or by e-mail.

Does Exercise Improve Lung Function?
As part of our quality improvement initiative we are doing a research study to look at the effect of exercise on lung function, nutrition, and quality of life. For information click here or contact Karen von Berg, PT, at 410-614-3234 or by email.